| A review of co‐morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co‐use RA Rabin, TP George The American journal on addictions 24 (2), 105-116, 2015 | 197 | 2015 |
| The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis RA Rabin, KK Zakzanis, TP George Schizophrenia research 128 (1-3), 111-116, 2011 | 187 | 2011 |
| Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls VC Wing, TG Moss, RA Rabin, TP George Addictive Behaviors 37 (1), 67-72, 2012 | 76 | 2012 |
| Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems KM Mackowick, MS Barr, VC Wing, RA Rabin, C Ouellet-Plamondon, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 52, 79-85, 2014 | 75 | 2014 |
| Effects of cannabis use status on cognitive function, in males with schizophrenia RA Rabin, KK Zakzanis, ZJ Daskalakis, TP George Psychiatry research 206 (2-3), 158-165, 2013 | 66 | 2013 |
| Co‐morbid tobacco use disorder and depression: A re‐evaluation of smoking cessation therapy in depressed smokers M Morozova, RA Rabin, TP George The American journal on addictions 24 (8), 687-694, 2015 | 61 | 2015 |
| Correlation of Prepulse Inhibition and Wisconsin Card Sorting Test in Schizophrenia and Controls: Effects of smoking status RA Rabin, KA Sacco, TP George Schizophrenia research 114 (1-3), 91-97, 2009 | 47 | 2009 |
| Effects of extended cannabis abstinence on cognitive outcomes in cannabis dependent patients with schizophrenia vs non-psychiatric controls RA Rabin, MS Barr, MS Goodman, Y Herman, KK Zakzanis, SJ Kish, ... Neuropsychopharmacology 42 (11), 2259-2271, 2017 | 44 | 2017 |
| Treatment implications associated with cannabis and tobacco co-use EA McClure, RA Rabin, DC Lee, C Hindocha Current addiction reports 7, 533-544, 2020 | 42 | 2020 |
| Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies MA Parvaz, RA Rabin, F Adams, RZ Goldstein Drug and alcohol dependence 232, 109319, 2022 | 38 | 2022 |
| Does cannabis use moderate smoking cessation outcomes in treatment‐seeking tobacco smokers? Analysis from a large multi‐center trial RA Rabin, RL Ashare, RA Schnoll, PM Cinciripini, LW Hawk Jr, C Lerman, ... The American journal on addictions 25 (4), 291-296, 2016 | 32 | 2016 |
| Varenicline modulates spatial working memory deficits in smokers with schizophrenia. VC Wing, CE Wass, I Bacher, RA Rabin, TP George Elsevier Science, 2013 | 31 | 2013 |
| Understanding the link between cannabinoids and psychosis RA Rabin, TP George Clinical Pharmacology & Therapeutics 101 (2), 197-199, 2017 | 26 | 2017 |
| Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls RA Rabin, K Kozak, KK Zakzanis, G Remington, TP George Schizophrenia research 194, 55-61, 2018 | 25 | 2018 |
| A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls RA Rabin, K Kozak, KK Zakzanis, G Remington, C Stefan, AJ Budney, ... Schizophrenia research 194, 47-54, 2018 | 20 | 2018 |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness K Kozak, P H. Smith, DJE Lowe, AH Weinberger, ZD Cooper, RA Rabin, ... The American journal of drug and alcohol abuse 47 (5), 535-547, 2021 | 18 | 2021 |
| Common and gender-specific associations with cocaine use on gray matter volume: Data from the ENIGMA addiction working group RA Rabin, S Mackey, MA Parvaz, J Cousijn, CS Li, G Pearlson, ... Human brain mapping, 2020 | 18 | 2020 |
| Relationship between tobacco and cannabis use status in outpatients with schizophrenia RA Rabin, JL Giddens, TP George The American Journal on Addictions 23 (2), 170-175, 2014 | 16 | 2014 |
| Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia KK Bidzinski, DJE Lowe, M Sanches, M Sorkhou, I Boileau, M Kiang, ... Schizophrenia 8 (1), 2, 2022 | 15 | 2022 |
| Nicotinic receptor mechanisms in neuropsychiatric disorders: therapeutic implications I Bacher, RA Rabin, AA Woznica, S KA, G TP Primary Psychiatry 17 (1), 35-41, 2010 | 15 | 2010 |
